Representing cell cycle dataUBEZIO, P; CAPOLONGO, L.Cytometry (New York, N.Y.). 1986, Vol 7, Num 6, pp 609-611, issn 0196-4763Article

DNA damage and cytotoxicity of mitoxantrone and doxorubicin in doxorubicin-sensitive and -resistant human colon carcinoma cellsCAPOLONGO, L; BELVEDERE, G; D'INCALCI, M et al.Cancer chemotherapy and pharmacology. 1990, Vol 25, Num 6, pp 430-434, issn 0344-5704Article

Growth-inhibitory properties of novel anthracyclines in human leukemic cell lines expressing either Pgp-MDR or at-MDRMARIANI, M; CAPOLONGO, L; SUARATO, A et al.Investigational new drugs. 1994, Vol 12, Num 2, pp 93-97, issn 0167-6997Article

Reversal of multidrug resistance by new dihydropyridines with low calcium antagonist activityCAPOLONGO, L; AMBOLDI, N; BALLINARI, D et al.Acta oncologica (Stockholm). 1994, Vol 33, Num 7, pp 787-791, issn 0284-186XConference Paper

The antitumor efficacy of cytotoxic drugs is potentiated by treatment with PNU 145156E, a growth-factor-complexing moleculeSOLA, F; CAPOLONGO, L; MONETA, D et al.Cancer chemotherapy and pharmacology. 1999, Vol 43, Num 3, pp 241-246, issn 0344-5704Article

Sequence-specific DNA alkylation of novel tallimustine derivativesMARCHINI, S; COZZI, P; BERIA, I et al.Anti-cancer drug design. 1998, Vol 13, Num 3, pp 193-205, issn 0266-9536Article

Biological profile of FCE 24517, a novel benzoyl mustard analogue of distamycin APEZZONI, G; GRANDI, M; SPREAFICO, F et al.British journal of cancer. 1991, Vol 64, Num 6, pp 1047-1050, issn 0007-0920Article

Synthesis, solvolytic stability and cytotoxicity of a modified derivative of CPzI, a pyrazole analog of the alkylation subunit of the antitumor agent CC-1065 : Effect of the nitrogen substitution on the functional reactivityBARALDI, P. G; CACCIARI, B; GUIOTTO, A et al.Il Farmaco (Pavia). 1997, Vol 52, Num 12, pp 717-723, issn 0014-827XArticle

The alkylating antitumor drug tallimustine does not induce DNA repairROSSI, R; MONTECUCCO, A; CAPOLONGO, L et al.Anticancer research. 1996, Vol 16, Num 6B, pp 3779-3783, issn 0250-7005Article

Novel anthracycline analogsGRANDI, M; PEZZONI, G; BALLINARI, D et al.Cancer treatment reviews. 1990, Vol 17, Num 2-3, pp 133-138, issn 0305-7372, 6 p.Article

Novel phenyl nitrogen mustard and half-mustard derivatives of amidino-modified distamycinCOZZI, P; BERIA, I; BIASOLI, G et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 23, pp 2979-2984, issn 0960-894XArticle

Novel phenyl nitrogen mustard and half-mustard derivatives of distamycin ACOZZI, P; BERIA, I; MONGELLI, N et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 23, pp 2985-2990, issn 0960-894XArticle

Morpholinylanthracyclines : cytotoxicity and antitumor activity of differently modified derivativesRIPAMONTI, M; CAPOLONGO, L; MELEGARO, G et al.Investigational new drugs. 1996, Vol 14, Num 2, pp 139-146, issn 0167-6997Article

Temperature influences both cytotoxicity and DNA nicking efficiency of the antitumor distamycin analogue FCE24517MONTECUCCO, A; CAPOLONGO, L; MELEGARO, G et al.Anticancer research. 1994, Vol 14, Num 1A, pp 189-192, issn 0250-7005Article

Characterisation of a LoVo subline resistant to a benzoyl mustard derivative of distamycin A (FCE 24517)CAPOLONGO, L; MELEGARO, G; BROGGINI, M et al.British journal of cancer. 1993, Vol 68, Num 5, pp 916-919, issn 0007-0920Article

Phenyl sulfur mustard derivatives of distamycin ACOZZI, P; BERIA, I; CALDARELLI, M et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 15, pp 1653-1656, issn 0960-894XArticle

Cytotoxic halogenoacrylic derivatives of distamycin ACOZZI, P; BERIA, I; CALDARELLI, M et al.Bioorganic & medicinal chemistry letters (Print). 2000, Vol 10, Num 11, pp 1269-1272, issn 0960-894XArticle

Estimation of the haematological toxicity of minor groove alkylators using tests on human cord blood cellsGHIELMINI, M; BOSSHARD, G; CAPOLONGO, L et al.British journal of cancer. 1997, Vol 75, Num 6, pp 878-883, issn 0007-0920Article

Synthesis and cytotoxic activity of alkylidene- and alkyl-substituted camptothecinsCANDIANI, I; BEDESCHI, A; CABRI, W et al.Bioorganic & medicinal chemistry letters (Print). 1997, Vol 7, Num 7, pp 847-850, issn 0960-894XArticle

Decreased tyrosine phosphorylation in tumour cells resistant to FCE 24517 (tallimustine)CIOMEI, M; PASTORI, W; CAPOLONGO, L et al.British journal of cancer. 1995, Vol 72, Num 6, pp 1504-1508, issn 0007-0920Article

Influence of structural modifications at the 3' and 4' positions doxorubicin on the drug ability to trap topoisomerase II and to overcome multidrug resistanceCAPRANICO, G; SUPINO, R; BINASCHI, M et al.Molecular pharmacology. 1994, Vol 45, Num 5, pp 908-915, issn 0026-895XArticle

Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides : synthesis and biological activityCRISTALLI, G; VITTORI, S; ELEUTERI, A et al.Journal of medicinal chemistry (Print). 1991, Vol 34, Num 7, pp 2226-2230, issn 0022-2623, 5 p.Article

Antiproliferative properties of flavone acetic acid (NSC 347512) (LM 975), a new anticancer agentCAPOLONGO, L. S; BALCONI, G; UBEZIO, P et al.European journal of cancer & clinical oncology. 1987, Vol 23, Num 10, pp 1529-1535, issn 0277-5379Article